Association of iron infusion reactions with ABO blood type
Authors:
- 9 August 2022
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 109 (5) , 519-525
Abstract
Objectives We sought to determine risk factors for iv iron infusion-related reactions (IRR), and identify strategies for iron repletion after IRR. Methods We conducted a retrospective chart review of patients treated in the classical hematology clinic at Yale Cancer Center (n = 330 consecutive patients) from 2016 to 2021, who received iv ferumoxytol (60.3%), iron sucrose (14.8%), or iron dextran (10.9%). Results The iv iron IRR was noted in 58 (17.6%) patients, 62.1% of whom had previously tolerated iv iron. The severity of IRR was mild in 22, moderate in 23, and severe in 11 patients. Most (72.4%) patients who experienced IRR tolerated a subsequent iv iron infusion. On multivariable analysis, a history of non-medication allergies was associated with greater odds of IRR (odds ratio [OR] 2.12, 95% confidence interval (CI): 1.16-3.87, p = .01). No patients with type AB blood, and few with type A blood (n = 6), had IRR; compared to type A or AB together, patients with type B (OR 5.00, 95% CI: 1.56-16.06, p = .007) or type O (OR 3.71, 95% CI: 1.44-9.55, p = .007) blood had greater odds of IRR. Conclusions This study highlights a possible association of blood type with iv iron IRR; prospective studies with larger patient numbers are warranted to explore this association.Keywords
This publication has 30 references indexed in Scilit:
- Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-AnalysisPLOS ONE, 2015
- The Safety of Intravenous Iron PreparationsMayo Clinic Proceedings, 2015
- Hypersensitivity reactions to intravenous iron: guidance for risk minimization and managementHaematologica, 2014
- A systematic analysis of global anemia burden from 1990 to 2010Blood, 2014
- Red meat allergy in Sweden: Association with tick sensitization and B-negative blood groupsJournal of Allergy and Clinical Immunology, 2013
- Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemiaAmerican Journal of Hematology, 2013
- Safety of Ferumoxytol in Patients With Anemia and CKDAmerican Journal of Kidney Diseases, 2008
- Safe Administration of Iron Sucrose in a Patient with a Previous Hypersensitivity Reaction to Ferric GluconatePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Safe Administration of Iron Dextran to a Patient Who Reacted to the Test DoseSouthern Medical Journal, 1994
- Associations between atopic diseases and the polymorphic systems ABO, kidd, inv and red cell acid phosphataseHuman Genetics, 1979